BRD4 and adenoid cystic carcinoma: For example, JQ1, a BET inhibitor, broke up super-enhancers by inhibiting BRD4 and deregulating MYB transcription, consequently inhibiting adenoid cystic carcinoma growth (Drier et al., 2016).